Prev:Serum orexin-A levels are associated with disease progression and motor impairment in multiple sclerosis(KTE61518-2.285)
Next:The Evaluation of Glutathione Reductase and Malondialdehyde Levels in Patients With Lumbar Disc Degeneration Disease(KTE61683-1.5)